(1-Methyl-4-piperidinyl)methanamine 99%

Since our inception in 2004, AR Life Sciences into manufacturing of bulk drug Intermediates and served our customers with great quality products. From 2014 onwards, we ventured into Active Pharmaceutical Ingredients (API) manufacturing after acquiring Dymes Pharmachem Ltd(which subsequently got merged into A R Life Sciences). Our core competence is to cater to ever changing and evolving requirements of our quality conscious clients who are looking for manufacturers committed to quality along with timely delivery and compitative prices. We have recently developed many basic and advanced intermediates and APIs at our in-house R & D center to cater to existing and new customers.

Our commitment to quality and customer delight has been a key strength contributing to our growth and success. Our research and development division constantly strives to improve existing processes(within the regulatory framework) for cost reduction, develop new intermediates and perform custom synthesis as per customer’s requirements. The same helped us in building and maintaining a clientele comprising many prominent pharmaceutical companies including Dr. Reddy’s Laboratories Limited, Emcure Pharmaceuticals, Aurobindo, Cipla, Cadila Healthcare, Lupin, Olon SPA, Uquifa, and many other domestic and multinational customers.

R & D Services

We are empowered by a team of well experienced and dedicated scientists who are constantly involved in generating new ideas and implementing those in order to develop new APIs and API Intermediates. We also provide various R&D services to meet our customer’s diverse requirements. We also maintain strict confidentiality with respect to any of the R&D services provided to clients on exclusive basis.